IL10 and non-Hodgkin lymphoma: These studies explain and agree with our results because the values of IL-6 and IL-10 levels were found to be higher in patients post treatment and different post-treatment subgroups compared with the control healthy volunteers in HL and NHL reflecting an association between elevated serum levels of those cytokines and aggressive disease and resistance to the used chemotherapy.